<DOC>
	<DOCNO>NCT01585727</DOCNO>
	<brief_summary>One major problem rectal cancer surgery pelvic autonomic nerve damage , main cause urogenital dysfunction influence postoperative quality life . Costs diagnostics treatment short long-term urogenital dysfunction immense . Varying degree urogenital dysfunction find 32 % 55 % patient rectal cancer despite potentially nerve-sparing total mesorectal excision ( TME ) . The study examine impact newly develop continuous monitoring device preservation urogenital function patient TME rectal cancer . 188 patient include prospective , randomize , single-blind , parallel group multi-centre trial include two arm ( TME without intraoperative continuous monitoring pelvic autonomic nerve ) . The primary efficacy endpoint change urinary function measure International Prostate Function Score ( IPSS ) 12 month surgery . Genital function measure secondary endpoint . The application continuous intraoperative neuromonitoring device could enhance objective intraoperative confirmation pelvic nerve spar surgery . The investigator hypothesis use device minimizes risk postoperative urogenital dysfunction patient TME rectal cancer . An enormous reduction treatment cost expect .</brief_summary>
	<brief_title>Intraoperative Monitoring Pelvic Autonomic Nerves</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>informed consent histologically confirm carcinoma rectum ( â‰¤ 16 cm anal verge ) fit radical surgery total mesorectal excision age 1880 year history operation urinary tract ( e.g . prostatectomy ) pacemaker emergency operation multivisceral resection pelvis partial mesorectal excision eligibility local excision ( TEM , intestinal wall resection ) ongoing infection sepsis severe untreated physical mental impairment pregnancy breastfeed woman childbearing potential use highly effective birth control method miss preoperative data urogenital anorectal function simultaneous participation another clinical trial previous participation clinical trial lack cooperation trial procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Rectal cancer</keyword>
	<keyword>total mesorectal excision</keyword>
	<keyword>pelvic autonomic nerve preservation</keyword>
	<keyword>neurostimulation</keyword>
	<keyword>urogenital function</keyword>
	<keyword>quality life</keyword>
</DOC>